Lung Cancer - Other

JANS Article

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP Statement on Management of Incidental Findings from Low-Dose CT Screening for Lung Cancer

November 20, 2023 | EACTS StaffSilver Contributor

Lung cancer screening with low-dose CT is being introduced in several European countries. The management of incidental findings, both pulmonary and extrapulmonary, is an important component of the clinical and cost effectiveness of screening programs....

JANS Article

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

November 10, 2023 | Aristotle ProtopapasGold Commentor

A manuscript that wil certainly be discussed in lung MDT! The thought of a RCT in these earlier stages may be already in the mind of the sponsors… The authors...

JANS Article

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography

April 19, 2023 | Mark FergusonBronze Contributor

This study used lung cancer screening trial low dose CT scans to develop a model (Sybil) that predicts the likelihood of development of a lung cancer within the next year....

JANS Article

Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery Guidelines for the Prevention of Cancer-Associated Venous Thromboembolism in Thoracic Surgery

March 23, 2023 | Cameron LindSilver Contributor

Thoracic oncology patients are a high-risk group for venous thromboembolism (VTE). The ESTS and AATS panel reviewed the evidence using the GRADE approach and made twenty-four recommendations for VTE prophylaxis,...

JANS Article

FDA Approves Drug Which Makes Lung Cancer Glow

January 6, 2023 | Cameron LindSilver Contributor

The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light....

JANS Article

Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-Stage Lung Cancer

December 9, 2022 | Cameron LindSilver Contributor

This study aimed to measure the population-level impact of federal lung cancer screening recommendations and Medicare coverage. After these decisions were implemented, and when adjusted for age, researchers found that...

JANS Article

Access to Care Metrics in Stage I Lung Cancer: Improved Access Is Associated with Improved Survival

November 4, 2022 | Cameron LindSilver Contributor

Although equitable access to care is critical to proper surgical lung cancer management, quality measures (QMs) that assess preoperative access to care are lacking. This study determined the relationship between...

JANS Article

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline

February 8, 2020 | Mark FergusonBronze Contributor

The newest version of the ASCO guidelines for lung cancer surveillance after curative lung cancer therapy is presented. The overall quality of supportive evidence is low, and the strength of...

JANS Article

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

February 1, 2020 | Mark FergusonBronze Contributor

Individuals at high risk for lung cancer were randomized to low dose CT screening (years 0, 1, 3, and 5.5) or observation. At 10 years the cumulative rate ratio for...

JANS Article

A Remarkable Drop in Lung Cancer Mortality

January 10, 2020 | Mark FergusonBronze Contributor

Declines in US annual lung cancer mortality rates of 5% for men and 4% for women led improvements in overall cancer mortality rates in the latest update from the American...

JANS Article

Long-Term Cancer Risk Associated With Lung Nodules Observed on Low-Dose Screening CT Scans

January 10, 2020 | Mark FergusonBronze Contributor

Benign-appearing lung nodules identified on screening CTs are associated with an increased risk of lung cancer diagnosis 4 to 8 and 8 to 11 years after the scan (RRs 1.9...

JANS Article

Cardiorespiratory Fitness, Lung Cancer Incidence, and Cancer Mortality in Male Smokers

October 21, 2019 | Mark FergusonBronze Contributor

Better cardiorespiratory fitness as quantified by treadmill exercise testing was associated with a substantially decreased likelihood of lung cancer in former smokers (77% reduction in very fit) and reduced mortality...

JANS Article

Prediction of Response to Anti-PD-1 Therapy in Patients With Non-small-cell Lung Cancer by Electronic Nose Analysis of Exhaled Breath

September 20, 2019 | Mark FergusonBronze Contributor

Immune checkpoint inhibitors have revolutionized treatment of non-small cell lung cancer. In this study, breath prophiles were collected from 143 patients and a single biomarker profile was created that detected...

LOAD MORE
ADVERTISE ON CTSNET